About Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C
"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments, and email. This allows you to still get great care while helping to address the community spread of COVID-19. If you’re concerned about your specific health condition, call 1-833-KP4CARE (1-833-574-2273) (TTY 711) to talk to a licensed care provider 24/7. For answers to your general questions about COVID-19, call our new information line for Kaiser Permanente members at 1-877-813-7297."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Novartis Pharmaceuticals
4
Clinical Trials at Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C
During the past decade, Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutation With Advanced Breast Cancer Who Have Progressed on or After Prior Treatments
2017-08-14
2025-07-17
Active, not recruiting
383
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C
According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C" are
"Breast Cancer" (2 trials), "Advanced Breast Cancer" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C" in a lesser frequency.
Clinical Trials Intervention Types at Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C
Most popular intervention types in "Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Everolimus" (2 trials), "Exemestane" (2 trials), "Alpelisib" (1 trials), "Dexamethasone based mouthwash" (1 trials) and "Everolimus Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C
The vast majority of trials in "Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C" are
2 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C
Currently, there are NaN active trials in "Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kaiser Permanente Medical Group Kaiser Permanente-Moanalua M.C, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".